The TLR4–NF-κB pathway has been intensively studied in several cancers such as laryngeal carcinoma and ovarian carcinoma as prognostic markers and inhibiting of the pathway might serve as a potential treatment of the cancers. This evidence concerns the gene TLR4 and ovarian carcinoma.